Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee

Shaji Kumar, Lawrence Baizer, Natalie S. Callander, Sergio A. Giralt, Jens Hillengass, Boris Freidlin, Antje Hoering, Paul G. Richardson, Elena I. Schwartz, Anthony Reiman, Suzanne Lentzsch, Philip L. McCarthy, Sundar Jagannath, Andrew J. Yee, Richard F. Little, Noopur S. Raje

Open source

DOI: 10.1038/s41408-022-00695-5
Published: 2022-06-29
Container: Blood Cancer Journal
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41408-022-00695-5,
  title = {Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee},
  author = {Shaji Kumar and Lawrence Baizer and Natalie S. Callander and Sergio A. Giralt and Jens Hillengass and Boris Freidlin and Antje Hoering and Paul G. Richardson and Elena I. Schwartz and Anthony Reiman and Suzanne Lentzsch and Philip L. McCarthy and Sundar Jagannath and Andrew J. Yee and Richard F. Little and Noopur S. Raje},
  year = {2022},
  journal = {Blood Cancer Journal},
  doi = {10.1038/s41408-022-00695-5},
  url = {https://doi.org/10.1038/s41408-022-00695-5}
}

RIS

TY  - JOUR
TI  - Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee
AU  - Shaji Kumar
AU  - Lawrence Baizer
AU  - Natalie S. Callander
AU  - Sergio A. Giralt
AU  - Jens Hillengass
AU  - Boris Freidlin
AU  - Antje Hoering
AU  - Paul G. Richardson
AU  - Elena I. Schwartz
AU  - Anthony Reiman
AU  - Suzanne Lentzsch
AU  - Philip L. McCarthy
AU  - Sundar Jagannath
AU  - Andrew J. Yee
AU  - Richard F. Little
AU  - Noopur S. Raje
PY  - 2022
JO  - Blood Cancer Journal
DO  - 10.1038/s41408-022-00695-5
UR  - https://doi.org/10.1038/s41408-022-00695-5
ER  -

APA

Kumar, S., Baizer, L., Callander, N. S., Giralt, S. A., Hillengass, J., Freidlin, B., Hoering, A., Richardson, P. G., Schwartz, E. I., Reiman, A., Lentzsch, S., McCarthy, P. L., Jagannath, S., Yee, A. J., Little, R. F., & Raje, N. S. (2022). Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee. Blood Cancer Journal. https://doi.org/10.1038/s41408-022-00695-5

Source records

crossref · retrieved 2026-09-26T17:16:54.785Z